Nexgel (NXGL) EBITDA (2018 - 2025)

Nexgel (NXGL) reported EBITDA of $1.5 million for Q4 2025, up 281.93% on a YoY basis from $400600.9 in Q4 2024, and up 311.03% quarter-over-quarter from -$725000.0 in Q3 2025.

Nexgel (NXGL) EBITDA (2018 - 2025) Analysis & Trends

Nexgel has reported EBITDA for 8 years, with the latest figure at $1.5 million in Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 281.93% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$608000.0 (up 82.89% YoY), and the FY2025 full-year result was -$608000.0, up 82.89% from the prior year.
  • EBITDA for Q4 2025 stood at $1.5 million, up from -$725000.0 in the prior quarter.
  • The five-year high for EBITDA was $1.5 million in Q4 2025, with the low at -$1.2 million in Q4 2023.
  • Historically, EBITDA has averaged -$677800.0 across 5 years, with a median of -$779000.0 in 2022.
  • Annual changes were most pronounced in 2022 — EBITDA sank 70.0% — and 2025, when it jumped 281.93%.
  • Nexgel's EBITDA stood at -$887000.0 in 2021, then advanced by 11.95% to -$781000.0 in 2022, then slumped by 56.08% to -$1.2 million in 2023, then surged by 31.01% to -$841000.0 in 2024, then jumped by 281.93% to $1.5 million in 2025.
  • The last three EBITDA figures came in at $1.5 million (Q4 2025), -$725000.0 (Q3 2025), and -$636000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 799.70 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 93.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 120.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 499.81 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 177.10 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 81.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -107.10 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 141.96 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 66.00 Mn
10 Nexgel 4.18 Mn 2.81 Mn 819,000.00 1.53 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.53 Mn
Sep 30, 2025 -725,000.00
Jun 30, 2025 -636,000.00
Mar 31, 2025 -777,000.00
Dec 31, 2024 -841,000.00
Sep 30, 2024 -788,000.00
Jun 30, 2024 -1.05 Mn
Mar 31, 2024 -871,000.00
Dec 31, 2023 -1.22 Mn
Sep 30, 2023 -612,000.00
Jun 30, 2023 -762,000.00
Mar 31, 2023 -883,000.00
Dec 31, 2022 -781,000.00
Sep 30, 2022 -1.04 Mn
Jun 30, 2022 -718,000.00
Mar 31, 2022 -812,000.00
Dec 31, 2021 -887,000.00
Sep 30, 2021 -610,000.00
Jun 30, 2021 -553,000.00
Mar 31, 2021 -520,000.00